Role of the thymus in the development of tolerance and autoimmunity towards the neuroendocrine system

Annals of the New York Academy of Sciences

Volumn 992, Issue , 2003, Pages 186-195

  Geenen, Vincent ^a   Brilot, Fabienne ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

IGF 2; Insulin; Thymus; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; INSULIN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C; VACCINE;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONFERENCE PAPER; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTOPENIA; LYMPHOID ORGAN; MACROPHAGE; NEUROENDOCRINE SYSTEM; NONHUMAN; PANCREAS ISLET BETA CELL; STROMA; T LYMPHOCYTE; THYMUS;

ANIMALIA;

EID: 0037791703     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03149.x     Document Type: Conference Paper

References (55)

1. PASCHKE, R. & V. GEENEN. 1995. Messenger RNA expression for a TSH receptor variant in the thymus of a two-year-old child. J. Mol. Med. 73: 577-580.
2. MURAKAMI, M., Y. HOSOI, T. NEGISHI, et al. 1996. Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus. J. Clin. Invest. 98: 2228-2234.
3. SMITH, K.M., D.C. OLSON, R. HIROSE & D. HANAHAN. 1997. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance. Intern. Immunol. 9: 1355-1365.
4. EGWUAGU, C.E., P. CHARUKAMNOETKANOK & I. GERY. 1997. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 159: 3109-3112.
5. FARR, A.G. & A. RUDENSKY. 1998. Medullary thymic epithelium: a mosaic of epithelial "self"? J. Exp. Med. 188: 1-4.
6. HEATH, V.L., N.N. MOORE, S.M. PARNELL & D.W. MASON. 1998. Intrathymic expression of genes involved in organ specific autoimmune diseases. J. Autoimmunol. 11: 309-318.
7. WERDELIN, O., U. CORDES & T. JENSEN. 1998. Aberrant expression of tissue specific proteins in the thymus: a hypothesis for the development of central tolerance. Scand. J. Immunol. 47: 95-100.
8. SALMON, A.M., C. BRUAND, A. CARDONA, et al. 1998. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and autoreactivity in myasthenia gravis. J. Clin. Invest. 101: 2340-2350.
9. SOSPEDRA, M., X. FERRER-FRANCESCH, O. DOMINGUEZ, et al. 1999. Transcription of a broad-range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J. Immunol. 161: 5918-5929.
10. KLEIN, L., M. KLUGMANN, K.-A. NAVE, et al. 2000. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6: 56-61.
11. KYEWSKI, B., J. DERBINSKI, J. GOTTER & L. KLEIN. 2002. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol. 23: 364-371.
12. GEENEN, V., J.J. LEGROS, P. FRANCHIMONT, et al. 1986. The neuroendocrine thymus: coexistence of oxytocin and neurophysin in the human thymus. Science 232: 508-511.
13. ROBERT, F.R., H. MARTENS, N. CORMANN, et al. 1992. The recognition of hypothalamo-neurohypophysial functions by developing T cells. Dev. Immunol. 2: 131-140.
14. MARTENS, H., B. MAGRANGE, F. ROBERT, et al. 1996. Cytokine production by human thymic epithelial cells: control by the immune recognition of the neurohypophysial self-antigen. Regul. Pept. 67: 39-45.
15. GEENEN, V., E. VANDERSMISSEN, N. CORMANN-GOFFIN, et al. 1993. Membrane translocation and relationship with MHC class I of a human thymic neurophysin-like protein. Thymus 22: 55-66.
16. NORTH, W.G. 2000. Gene regulation of vasopressin and vasopressin receptors in cancer. Exp. Physiol. 85: 27s-40s.
17. SUNDLER, F., R.E. CARRAWAY, R. HAKANSON, et al. 1978. Immunoreactive neurotensin and somatostatin in the chicken thymus. Cell Tiss. Res. 194: 367-376.
18. VANNESTE, Y., A. NTODOU THOME, E. VANDERSMISSEN, et al. 1997. Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I molecules. J. Neuroimmunol. 76: 161-166.
19. HANSENNE, I., G. RASIER, M.P. DEFRESNE, et al. 2003. Neurohypophysial receptor gene expression by thymic T cell subsets and thymic T cell lymphoma cell lines. Dev. Immunol. In press.
20. MARTENS, H., F. ROBERT, J.J. LEGROS, et al. 1992. Expression of functional neurohypophysial peptide receptors by immature and cytotoxic T cell lines. Prog. NeuroEndocrinImmunol. 5: 31-39.
21. MARTENS, H., O. KECHA, C. CHARLET-RENARD, et al. 1998. Neurohypophysial peptides stimulate the phosphorylation of pre-T cell focal adhesion kinases. Neuroendocrinology 67: 282-289.
22. MARTENS, H., B. GOXE & V. GEENEN. 1996. The thymic repertoire of neuroendocrine-related self-antigens: physiological implications in T-cell life and death. Immunol. Today 17: 312-317.
23. rd Ed. G. Adelman & B.H. Smith, Eds. Elsevier. New York. In press.
24. GEENEN, V., I. ACHOUR, F. ROBERT, et al. 1993. Evidence that insulin-like growth factor-2 (IGF-2) is the dominant thymic peptide of the insulin superfamily. Thymus 21: 115-127.
25. KECHA, O., H. MARTENS, N. FRANCHIMONT, et al. Characterization of the insulin-like growth factor axis in the human thymus. J. Neuroendocrinol. 11: 435-440.
26. KECHA, O., F. BRILOT, H. MARTENS, et al. 2000. Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures. Endocrinology 141: 1209-1217.
27. JOLICŒUR, C., D. HANAHAN & K.M. SMITH. 1994. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in the thymus. Proc. Natl. Acad. Sci. USA 91: 6707-6711.
28. DERBINSKI, J., A. SCHULTE, B. KYEWSKI & L. KLEIN. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2: 1032-1039.
29. PUGLIESE, A., D. BROWN, D. GARZA, et al. 2001. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J. Clin. Invest. 107: 555-564.
30. VAFIADIS, P., S.T. BENNETT, J.A. TODD, et al. 1997. Insulin expression is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15: 289-292.
31. PUGLIESE, A., M. ZELLER, A. FERNANDEZ, JR., et al. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15: 293-297.
32. ADORINI, L., E. APPELLA, G. DORIA & Z.A. NAGY. 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 168: 2091-2104.
33. CABANIOLS, J.P., R. CIBOTTI, P. KOURILSKY, et al. 1994. Dose-dependent T cell tolerance to an immunodominant self-peptide. Eur. J. Immunol. 24: 1743-1749.
34. NAQUET, P., J. ELLIS, D. TIBENSKY, et al. 1988. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J. Immunol. 140: 2569-2578.
35. CHAILLOUS, L., H. LEFEVRE, C. THIVOLET, et al. 2000. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Lancet 356: 545-549.
36. POZZILLI, P., D. PITOCCO, N. VISALLI, et al. 2000. No effect of oral insulin on residual beta-cell function in recent-onset type 1 diabetes (the IMDIAB VII). Diabetologia 43: 1000-1004.
37. DIABETES PREVENTION TRIAL-TYPE 1 DIABETES STUDY GROUP. 2002. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 346: 1685-1691.
38. KECHA-KAMOUN, O., I. ACHOUR, H. MARTENS, et al. 2001. Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes. Diabetes/Metab. Res. Rev. 17: 146-152.
39. TODD, J.A. 1995 Genetic analysis of type 1 diabetes using whole genome approaches. Proc. Natl. Acad. Sci. USA 92: 8560-8565.
40. CHENTOUFI, A.A. & C. POLYCHRONAKOS. 2002. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance. The mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51: 1383-1390.
41. HEINO, M., P. PETERSON, N. SILLANPAA, et al. 2000. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB deficient and in NOD mice. Eur. J. Immunol. 30: 1884-1893.
42. ZUKLYS, S., G. BALCIUNAITE, A. AGARWAL, et al. 2000. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J. Immunol. 165: 1976-1983.
43. ANDERSON, M.S., E.S. VENANZI, L. KLEIN, et al. 2002. Projection of an immunological self-shadow within the thymus by the Aire protein. Science 298: 1395-1401.
44. ERICSSON, A., V. GEENEN, F. ROBERT, et al. 1990. Expression of preprotachykinin A and neuropeptide Y mRNA in the thymus. Mol. Endocrinol. 4: 1211-1218.
45. SEBZDA, E., V.A. WALLACE, J. MAYER, et al. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263: 1615-1618.
46. KISHIMOTO, H. & J. SPRENT. A defect in central tolerance in NOD mice. Nat. Immunol. 2: 1025-1031.
47. BRILOT, F., W. CHEHADEH, C. CHARLET-RENARD, et al. 2002. Persistent infection of human thymic epithelial cells by coxsackievirus B4. J. Virol. 76: 5260-5265.
48. HORWITZ, M.S. & N. SARVETNICK. 1999. Viruses, host responses and autoimmunity. Immunol. Rev. 169: 241-253.
49. LEE, K.H., K. WUCHERPFENNIG & D.C. WILEY. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2: 501-507.
50. ALLEVA, D.G., P.D. CROWE, L. JIN, et al. 2001. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J. Clin. Invest. 107: 173-180.
51. ALLEVA, D.G., A. GAUR, L. JIN, et al. 2002. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 51: 2126-2134.
52. LIU, E., H. MORIYAMA, N. ABIRU, et al. 2002. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-33. J. Clin. Invest. 110: 1021-1027.
53. KARGES, W., K. PECHHOLD, S. AL DAHOUK, et al. 2002. Induction of autoimmune diabetes through insulin (but not GAD65) vaccination in non obese diabetic and in RIP-37.1 mice. Diabetes 51: 3237-3244.
54. COOKE, A., J.M. PHILLIPS & N.M. PARISH. 2001. Tolerogenic strategies to halt or prevent type 1 diabetes. Nat. Immunol. 2: 810-815.
55. YANG, Z., M. CHEN, R. WU, et al. 2002. Suppression of autoimmune diabetes by viral IL-10 gene transfer. J. Immunol. 168: 6479-6485.